Sort
15,440 grants matching “organoids”
Host-pathogen interactions during Staphylococcus aureus spine infections
$208,332Katherine Yenkhang Le · New York University School Of Medicine · K08 · FY2025 · AI
Targeting actionable liabilities in Merlin-deficient breast cancer
$208,271Lalita A. Shevde · University Of Alabama At Birmingham · R21 · FY2025 · CA
Research Project 3: Heterogeneity in metastatic CRPC and the role of TP53 mutation as a molecular determinant
$208,235Charles L Sawyers · Sloan-Kettering Inst Can Research · P50 · FY2020 · CA
Administrative Core: 3D Models of Engineered Human iPS Cells to Investigate Neurotropic Virus Infections
$208,219Lee Gehrke · Massachusetts Institute Of Technology · U19 · FY2019 · AI
Development of cell-based models for fibrolamellar carcinoma
$208,080Khashayar Vakili · Boston Children'S Hospital · R21 · FY2023 · CA
Developing a novel therapeutic strategy for overcoming resistance to PD-1 blockade in Triple-negative breast cancer
$208,038Chunyan Zhang · Beckman Research Institute/City Of Hope · R21 · FY2024 · CA
Human Cells and Tissues Core: 3D Models of Engineered Human iPS Cells to Investigate Neurotropic Virus Infections
$207,764Lee Gehrke · Massachusetts Institute Of Technology · U19 · FY2018 · AI
Core B - Pathology and Biospecimen Core
$207,657Sicinska · Dana-Farber Cancer Inst · P50 · FY2021 · CA
Functional Characterization of HER Family Variant Biology and Resistance in Cancer
$207,616Tikvah K Hayes · University Of California Los Angeles · R00 · FY2025 · CA
MicroRNA-based interventions to prevent progression from lung preneoplasia to adenocarcinoma
$207,600Roy S Herbst · Yale University · P50 · FY2017 · CA
Research Project
$207,600Frank J. Slack · Yale University · P50 · FY2018 · CA
Research Project
$207,600Frank J. Slack · Yale University · P50 · FY2017 · CA
Spatial patterns of metals and metal mixtures in drinking water
$207,555Elsie Mareca Sunderland · Harvard School Of Public Health · P42 · FY2022 · ES
Inter-tissue and -individual variability in responses to mixtures
$207,512Ivan Rusyn · Texas A&M University · P42 · FY2017 · ES
Investigating GSTP1 as a novel regulator of the cysteine redoxome in breast cancer and maker of vulnerability to redox-based therapy
$207,185Jason M. Held · Washington University · R21 · FY2024 · CA
Microbiota-Mediated Bidirectional Interactions Between Alcohol Misuse and Post-COVID-19 Syndrome
$207,052Ali Keshavarzian · Rush University Medical Center · R01 · FY2023 · AA
Human astrovirus infection of human intestinal enteroids
$206,950Christiane Wobus · University Of Michigan At Ann Arbor · R21 · FY2019 · AI
UAB Childhood Cystic Kidney Disease Core Center (UAB-CCKDCC)
$206,877Bradley K. Yoder · University Of Alabama At Birmingham · U54 · FY2021 · DK
Patient-derived organoids reveal rectal cancers develop radiosensitivity
$206,869Richard N Kolesnick · Sloan-Kettering Inst Can Research · R21 · FY2021 · CA
Project-004
$206,854Lori L Isom · University Of Michigan At Ann Arbor · U54 · FY2021 · NS
Building microenvironment-containing organoids from patient samples with single-cell precision
$206,703Scott R Manalis · Massachusetts Institute Of Technology · R21 · FY2021 · CA
A matrix metalloproteinase biosensor-functionalized metastasis-on-a-chip platform for evaluating adrenocortical carcinoma progression
$206,689Aleksander Skardal · Ohio State University · R21 · FY2024 · CA
Targeting casein kinase 1-alpha for cancer therapy
$206,539Steven Muntean Corsello · Stanford University · K08 · FY2022 · CA
Targeting casein kinase 1-alpha for cancer therapy
$206,539Steven Muntean Corsello · Dana-Farber Cancer Inst · K08 · FY2018 · CA
Targeting casein kinase 1-alpha for cancer therapy
$206,539Steven Muntean Corsello · Dana-Farber Cancer Inst · K08 · FY2019 · CA